View This Report »
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...
About Multiple Myeloma Drugs Multiple myeloma is an abnormal growth and accumulation of plasma cells in the bone marrow leading to malignancy. This can be caused by the overproduction of monoclonal immunoglobulins ...
2016 Global Small Molecule Kinase Inhibitor Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Small Molecule Kinase Inhibitor industry, ...